Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: Preliminary findings

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Marballi, Ketan ^a   Cruz, Dianne ^a   Thompson, Peter ^a   Walss Bass, Consuelo ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM19 PROTEIN; BETA SECRETASE 1; GAMMA SECRETASE; N TERMINAL FRAGMENT NEUREGULIN 1; NEU DIFFERENTIATION FACTOR; PRESENILIN 1; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; ADAM19 PROTEIN, HUMAN; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; NRG1 PROTEIN, HUMAN; SECRETASE; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

AGE; ANXIETY; ARTICLE; BIPOLAR DISORDER; BIPOLAR INVENTORY OF SIGNS AND SYMPTOMS SCALE; BRAIN WEIGHT; BRODMANN AREA 9; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ENDOPHENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MANIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NERVE CELL MEMBRANE; PH; PREFRONTAL CORTEX; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY; UPREGULATION; CLINICAL TRIAL; FEMALE; METABOLISM; PATHOLOGY; PROTEIN DEGRADATION;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; BIPOLAR DISORDER; COHORT STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; MALE; NEUREGULIN-1; PREFRONTAL CORTEX; PROTEOLYSIS; SCHIZOPHRENIA;

EID: 84861013015     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036431     Document Type: Article

References (43)

1. Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K, (2004) Neuregulin 1 and schizophrenia. Ann Med 36: 62-71.
2. Blackwood DH, Pickard BJ, Thomson PA, Evans KL, Porteous DJ, et al. (2007) Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. Neurotox Res 11: 73-83.
3. Walker RM, Christoforou A, Thomson PA, McGhee KA, Maclean A, et al. (2010) Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder. Neurosci Lett 478: 9-13.
4. Liu X, Bates R, Yin DM, Shen C, Wang F, et al. (2011) Specific regulation of NRG1 isoform expression by neuronal activity. J Neurosci 31: 8491-8501.
5. Linggi B, Carpenter G, (2006) ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol 16: 649-656.
6. Yokozeki T, Wakatsuki S, Hatsuzawa K, Black RA, Wada I, et al. (2007) Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin beta1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells. Genes Cells 12: 329-343.
7. Mei L, Xiong WC, (2008) Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 9: 437-452.
8. Bao J, Lin H, Ouyang Y, Lei D, Osman A, et al. (2004) Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nat Neurosci 7: 1250-1258.
9. Dejaegere T, Serneels L, Schafer MK, Van Biervliet J, Horre K, et al. (2008) Deficiency of Aph1B/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment. Proc Natl Acad Sci U S A 105: 9775-9780.
10. Savonenko AV, Melnikova T, Laird FM, Stewart KA, Price DL, et al. (2008) Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc Natl Acad Sci U S A 105: 5585-5590.
11. Hanlon FM, Houck JM, Pyeatt CJ, Lundy SL, Euler MJ, et al. (2011) Bilateral hippocampal dysfunction in schizophrenia. Neuroimage.
12. Radonic E, Rados M, Kalember P, Bajs-Janovic M, Folnegovic-Smalc V, et al. (2011) Comparison of hippocampal volumes in schizophrenia, schizoaffective and bipolar disorder. Coll Antropol 35 (Suppl 1): 249-252.
13. Doring TM, Kubo TT, Cruz LC Jr, Juruena MF, Fainberg J, et al. (2011) Evaluation of hippocampal volume based on MR imaging in patients with bipolar affective disorder applying manual and automatic segmentation techniques. J Magn Reson Imaging 33: 565-572.
14. van Veelen NM, Vink M, Ramsey NF, van Buuren M, Hoogendam JM, et al. (2011) Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia. Schizophr Res 129: 156-162.
15. Koike S, Takizawa R, Nishimura Y, Marumo K, Kinou M, et al. (2011) Association between severe dorsolateral prefrontal dysfunction during random number generation and earlier onset in schizophrenia. Clin Neurophysiol 122: 1533-1540.
16. Hassel S, Almeida JR, Kerr N, Nau S, Ladouceur CD, et al. (2008) Elevated striatal and decreased dorsolateral prefrontal cortical activity in response to emotional stimuli in euthymic bipolar disorder: no associations with psychotropic medication load. Bipolar Disord 10: 916-927.
17. Walss-Bass C, Liu W, Lew DF, Villegas R, Montero P, et al. (2006) A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol Psychiatry 60: 548.
18. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, et al. (2006) Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12: 824-828.
19. Boer S, Berk M, Dean B, (2009) Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder. Neurosci Lett 466: 27-29.
20. Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, et al. (2008) Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 100: 270-280.
21. Barakat A, Dean B, Scarr E, Evin G, (2010) Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia. Schizophr Res 124: 200-207.
22. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20: 22-33;quiz 34-57.
23. Montgomery SA, Asberg M, (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
24. Bowden CL, Singh V, Thompson P, Gonzalez JM, Katz MM, et al. (2007) Development of the bipolar inventory of symptoms scale. Acta Psychiatr Scand 116: 189-194.
25. Falls DL, (2003) Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284: 14-30.
26. Rybnikova E, Gluschenko T, Galeeva A, Tulkova E, Nalivaeva NN, et al. (2012) Differential expression of ADAM15 and ADAM17 metalloproteases in the rat brain after severe hypobaric hypoxia and hypoxic preconditioning. Neurosci Res 72: 364-373.
27. Muresan Z, Muresan V, (2006) Neuritic deposits of amyloid-beta peptide in a subpopulation of central nervous system-derived neuronal cells. Mol Cell Biol 26: 4982-4997.
28. Uemura K, Kuzuya A, Shimozono Y, Aoyagi N, Ando K, et al. (2007) GSK3beta activity modifies the localization and function of presenilin 1. J Biol Chem 282: 15823-15832.
29. American Psychiatric Association, (2000) Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th edn. American Psychiatric Association: Washington, DC, xxxvii, 943.
30. Holmes AJ, MacDonald A, 3rd, Carter CS, Barch DM, Andrew Stenger V, et al. (2005) Prefrontal functioning during context processing in schizophrenia and major depression: an event-related fMRI study. Schizophr Res 76: 199-206.
31. Townsend J, Bookheimer SY, Foland-Ross LC, Sugar CA, Altshuler LL, (2010) fMRI abnormalities in dorsolateral prefrontal cortex during a working memory task in manic, euthymic and depressed bipolar subjects. Psychiatry Res 182: 22-29.
32. Hall J, Whalley HC, Marwick K, McKirdy J, Sussmann J, et al. (2010) Hippocampal function in schizophrenia and bipolar disorder. Psychol Med 40: 761-770.
33. Wang XD, Su YA, Guo CM, Yang Y, Si TM, (2008) Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus. Int J Neuropsychopharmacol 11: 553-561.
34. Dutt A, McDonald C, Dempster E, Prata D, Shaikh M, et al. (2009) The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Psychol Med 39: 1783-1797.
35. Nason MW Jr, Adhikari A, Bozinoski M, Gordon JA, Role LW, (2011) Disrupted activity in the hippocampal-accumbens circuit of type III neuregulin 1 mutant mice. Neuropsychopharmacology 36: 488-496.
36. Kalinowski A, Plowes NJ, Huang Q, Berdejo-Izquierdo C, Russell RR, et al. (2010) Metalloproteinase-dependent cleavage of neuregulin and autocrine stimulation of vascular endothelial cells. FASEB J 24: 2567-2575.
37. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, et al. (2006) Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12: 824-828.
38. Kyosseva SV, Elbein AD, Griffin WS, Mrak RE, Lyon M, et al. (1999) Mitogen-activated protein kinases in schizophrenia. Biol Psychiatry 46: 689-696.
39. Parlapani E, Schmitt A, Wirths O, Bauer M, Sommer C, et al. (2010) Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients. World J Biol Psychiatry 11: 243-250.
40. Feng Y, Wang XD, Guo CM, Yang Y, Li JT, et al. (2010) Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration. J Biomed Biotechnol 2010 859516.
41. Chen Y, Hancock ML, Role LW, Talmage DA, (2010) Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. J Neurosci 30: 9199-9208.
42. Thompson PM, Gonzalez JM, Singh V, Schoolfield JD, Katz MM, et al. (2010) Principal domains of behavioral psychopathology identified by the Bipolar Inventory of Signs and Symptoms Scale (BISS). Psychiatry Res 175: 221-226.
43. Yamamoto K, Shimizu N, Obi S, Kumagaya S, Taketani Y, et al. (2007) Involvement of cell surface ATP synthase in flow-induced ATP release by vascular endothelial cells. Am J Physiol Heart Circ Physiol 293: H1646.